Literature DB >> 18702627

Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis.

D D Balci1, A Balci, S Karazincir, E Ucar, U Iyigun, F Yalcin, E Seyfeli, T Inandi, E Egilmez.   

Abstract

BACKGROUND: Psoriasis is associated with an increased risk of atherosclerosis. This study compared subclinical atherosclerosis of the carotid and brachial arteries in psoriasis vulgaris patients and healthy controls using high-resolution ultrasonography.
METHODS: We studied 43 psoriasis patients and 43 healthy controls matched for age and sex. Flow-mediated dilatation (FMD) and nitroglycerin-induced dilatation (NTD) of the brachial artery and intima-media thickness (IMT) of the common carotid arteries (CCA) were measured ultrasonographically. Diabetes mellitus, hypertension, renal failure, a history of cardiovascular or cerebrovascular disease were exclusion criteria. Subjects who were receiving lipid-lowering therapy, antihypertensive or anti-aggregant drugs, nitrates or long-term systemic steroids were also excluded.
RESULTS: The mean IMT values of the right, left and averaged CCA of the psoriasis patients were significantly higher, compared with the controls (0.607+/-0.144 mm vs. 0.532+/-0.101 mm, 0.611+/-0.157 mm vs. 0.521+/-0.117 mm, and 0.609+/-0.146 mm vs. 0.526+/-0.104 mm; P=0.006, P=0.003 and P=0.003, respectively). The mean FMD and NTD values of the psoriasis patients were significantly lower, compared with the controls (13.36+/-6.39 mm vs. 19.60+/-11.23 mm and 21.08+/-8.38 mm vs. 26.85+/-12.38 mm; P=0.002 and P=0.013, respectively). Multiple linear regression analysis revealed a significant association between psoriasis and the IMT, FMD and NTD. Moreover, the FMD in psoriasis patients was associated with disease duration.
CONCLUSION: Psoriasis patients had impaired endothelial function and thicker IMT of the CCA, compared with the healthy control subjects. The presence of psoriasis was an independent risk factor for subclinical atherosclerosis.

Entities:  

Mesh:

Year:  2008        PMID: 18702627     DOI: 10.1111/j.1468-3083.2008.02936.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  44 in total

1.  Psoriasis: it's more than just the skin.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

2.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Authors:  Nehal N Mehta; YiDing Yu; Babak Saboury; Negar Foroughi; Parasuram Krishnamoorthy; Anna Raper; Amanda Baer; Jules Antigua; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2011-05-16

Review 3.  Cardiometabolic Disorders in Psoriatic Disease.

Authors:  Curtis Sobchak; Lihi Eder
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

4.  The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.

Authors:  Alexander Egeberg; Lone Skov; Aditya A Joshi; Lotus Mallbris; Gunnar H Gislason; Jashin J Wu; Justin Rodante; Joseph B Lerman; Mark A Ahlman; Joel M Gelfand; Nehal N Mehta
Journal:  J Am Acad Dermatol       Date:  2017-08-18       Impact factor: 11.527

5.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 6.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

7.  Psoriasis and cardiovascular risk: strength in numbers.

Authors:  Joel M Gelfand; Rahat S Azfar; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2010-04       Impact factor: 8.551

Review 8.  Does treatment of psoriasis reduce the risk of cardiovascular disease?

Authors:  Sarah Churton; Liza Brown; Thuzar M Shin; Neil J Korman
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

9.  The risk of stroke in patients with psoriasis.

Authors:  Joel M Gelfand; Erica D Dommasch; Daniel B Shin; Rahat S Azfar; Shanu K Kurd; Xingmei Wang; Andrea B Troxel
Journal:  J Invest Dermatol       Date:  2009-05-21       Impact factor: 8.551

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.